These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 26379397

  • 1. Development of a rat model of D-galactosamine/lipopolysaccharide induced hepatorenal syndrome.
    Wang JB, Wang HT, Li LP, Yan YC, Wang W, Liu JY, Zhao YT, Gao WS, Zhang MX.
    World J Gastroenterol; 2015 Sep 14; 21(34):9927-35. PubMed ID: 26379397
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome].
    Saracyn M, Wesołowski P, Nowak Z, Patera J, Kozłowski W, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 14; 24(142):298-302. PubMed ID: 18634359
    [Abstract] [Full Text] [Related]

  • 5. Interfering RNA against PKC-α inhibits TNF-α-induced IP3R1 expression and improves glomerular filtration rate in rats with fulminant hepatic failure.
    Wang DL, Dai WY, Wang W, Wen Y, Zhou Y, Zhao YT, Wu J, Liu P.
    Am J Physiol Renal Physiol; 2018 May 01; 314(5):F942-F955. PubMed ID: 29357415
    [Abstract] [Full Text] [Related]

  • 6. Type I inositol 1, 4, 5-triphosphate receptors increase in kidney of mice with fulminant hepatic failure.
    Wen Y, Cui W, Liu P.
    World J Gastroenterol; 2007 Apr 28; 13(16):2344-8. PubMed ID: 17511035
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
    Uchida Y, Kaibori M, Hijikawa T, Ishizaki M, Ozaki T, Tanaka H, Matsui K, Tokuhara K, Kwon AH, Kamiyama Y, Okumura T.
    J Surg Res; 2008 Mar 28; 145(1):57-65. PubMed ID: 17936791
    [Abstract] [Full Text] [Related]

  • 8. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM.
    Eur J Pharmacol; 2014 Sep 05; 738():66-73. PubMed ID: 24877692
    [Abstract] [Full Text] [Related]

  • 9. [Description of an experimental model of hepatorenal syndrome in Wistar rats].
    Saracyn M, Kozłowski W, Wańikowicz Z.
    Pol Merkur Lekarski; 2004 Aug 05; 17(98):119-22. PubMed ID: 15603319
    [Abstract] [Full Text] [Related]

  • 10. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T, Tsujimoto T, Kawaratani H, Fukui H.
    J Gastroenterol Hepatol; 2010 May 05; 25(5):1009-12. PubMed ID: 20546456
    [Abstract] [Full Text] [Related]

  • 11. Hepatoprotective effect of germanium-containing Spirulina in rats with (D)-galactosamine- and lipopolysaccharide-induced hepatitis.
    Yoshinari O, Shiojima Y, Igarashi K.
    Br J Nutr; 2014 Jan 14; 111(1):135-40. PubMed ID: 23768655
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
    Furuya S, Kono H, Hara M, Hirayama K, Sun C, Fujii H.
    J Surg Res; 2015 Dec 14; 199(2):487-93. PubMed ID: 26141869
    [Abstract] [Full Text] [Related]

  • 13. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T, Hirono S, Moriuchi A, Hasuike S, Nagata K, Hori T, Ido A, Hayashi K, Tsubouchi H.
    Hepatology; 2001 Jun 14; 33(6):1441-50. PubMed ID: 11391533
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S, Yang N, Ni S, Li W, Xu L, Dong P, Lu M.
    Int J Clin Exp Pathol; 2014 Jun 14; 7(10):6626-34. PubMed ID: 25400741
    [Abstract] [Full Text] [Related]

  • 15. Age-Related Alterations in Blood Biochemical Characterization of Hepatorenal Function in the PCK Rat: A Model of Polycystic Kidney Disease.
    Shimomura Y, Brock WJ, Ito Y, Morishita K.
    Int J Toxicol; 2015 Jun 14; 34(6):479-90. PubMed ID: 26503599
    [Abstract] [Full Text] [Related]

  • 16. Pim-3 protects against hepatic failure in D-galactosamine (D-GalN)-sensitized rats.
    Liu LM, Zhang JX, Wang XP, Guo HX, Deng H, Luo J.
    Eur J Clin Invest; 2010 Feb 14; 40(2):127-38. PubMed ID: 20039932
    [Abstract] [Full Text] [Related]

  • 17. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
    Akashi I, Kagami K, Hirano T, Oka K.
    J Pharm Pharmacol; 2009 Apr 14; 61(4):473-8. PubMed ID: 19298694
    [Abstract] [Full Text] [Related]

  • 18. [Establishment of a D-galactosamine/lipopolysaccharide induced acute-on-chronic liver failure model in rats].
    Liu XH, Chen Y, Wang TL, Lu J, Zhang LJ, Song CZ, Zhang J, Duan ZP.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Oct 14; 15(10):771-5. PubMed ID: 17963606
    [Abstract] [Full Text] [Related]

  • 19. [Study on the expressions and roles of renal heat shock protein 72 and Toll-like receptor 4 in hepatorenal syndrome in rat].
    Yan CG, Zhu DF, Wang F.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec 14; 19(12):731-4. PubMed ID: 18093430
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury.
    Yoshida T, Abe K, Ikeda T, Matsushita T, Wake K, Sato T, Sato T, Inoue H.
    Eur J Pharmacol; 2007 Dec 08; 576(1-3):136-42. PubMed ID: 17825282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.